Zeta Pharma Pharmaceutical Industries

Zeta Pharma is a prominent Egyptian pharmaceutical company established in 2010 that specializes in the production of high-quality branded generic medications. The company rose to prominence through its significant contribution to Egypt's national initiative to eradicate Hepatitis C, providing effective antiviral treatments to tens of thousands of patients. Following its acquisition by the El-Banna Group in 2016, Zeta Pharma expanded its portfolio to include a wide array of therapeutic areas such as cardiovascular health, diabetes, and gastroenterology. The company operates a state-of-the-art manufacturing facility in Sadat City that adheres to WHO cGMP standards and is currently pursuing EMA accreditation to facilitate European exports. With a strong focus on affordability and innovation, Zeta Pharma serves markets across the Middle East, Africa, and Eastern Europe. Its commitment to excellence is reflected in its rapid growth and its role as a key supplier to the Egyptian Ministry of Health.